Occupational Asthma Management Beyond the Textbooks Paul Cullinan MD, FRCP

Size: px
Start display at page:

Download "Occupational Asthma Management Beyond the Textbooks Paul Cullinan MD, FRCP"

Transcription

1 Occupational Asthma 1 Professor of Occupational and Environmental Medicine Royal Brompton Hospital and Imperial College London LUNGS AT WORK Premise and plan Good respiratory physicians know a lot about occupational asthma But don t often see it And may not be sure about some of the intricacies Occupational asthma is rarely severe asthma but its consequences often are Intricacies by a single case report 2 Consider 3 47 year old No relevant past medical history Non-smoker September 2008: short of breath Dx chest infection by GP Christmas 2008: short of breath + wheeze 1/52 hospital Dx asthma Rx asthma since February 2009: returned to work Symptoms persist but better 2 week holiday in Crete: symptoms resolved Q1: what other information do you need? 1

2 Consider an occupational aetiology In every working adult with asthma that is: New Recurrent, or Deteriorating/Proving difficult to manage Especially if they are working with a recognised respiratory sensitising agent 4 Consider 22 years work in a factory making foam insulating board New process January

3 7 Consider 22 years work in a factory making foam insulating board New process January Q2: is it possible that his work is causally related to his diagnosis of asthma? or Is he working with a recognised respiratory sensitising agent? Most occupational asthma arises from specific sensitisation An agent at work is: Known to be a respiratory sensitiser (n 400) Known not to be a respiratory sensitiser Not known not to be respiratory sensitiser The last is tricky 9 3

4 Is your patient working with a respiratory sensitising agent? Agent on my familiar list? Consider OA 10 Respiratory sensitising agents: high molecular mass - Whole allergens 11 Occupation Baking Animal work Food processing Detergent manufacture Health care Exposure(s) Flour(s) Alpha amylase ( improver ) Egg Small mammals Large mammals Insects Latex Seafood Tea/coffee Eggs Flour Latex Etc. Enzymes Latex All induce specific IgE response Respiratory sensitising agents: low molecular mass + - Hapten-protein conjugates Occupation Spray painting Foam manufacture Electronic engineering Woodwork Hairdressing Dentistry Orthopaedics Textile printing Precious metal refining Exposure(s) Hexamethylene diisocyanate Toluene diisocyanate Methylene diphenyldiisocyanate Colophony fume Cyanoacrylate Persulphate salts Tropical wood dusts Persulphate salts Methacrylates Latex Reactive dyes Platinum salts 12 Some induce specific IgE response 4

5 Is your patient working with a respiratory sensitising agent? Agent on my familiar list? No/Not sure Seek advice obtain MSDS Consider OA R42? 13 No Take care Safety Data Sheet TECHNI GOLD 25 ES RTU TGOLD25ES/0 Page n. 1 of 4 Safety Data Sheet dated 23/7/2004, version 0 1. IDENTIFICATION OF THE PRODUCT AND THE COMPANY Trade name: TECHNI GOLD 25 ES RTU Trade code: TGOLD25ES Supplier: TECHNIC FRANCE 15rue de la Montjoie St Denis La Plaine 2. COMPOSITION/INFORMATION ON INGREDIENTS Hazardous components within the meaning of EEC directive 67/548 and corresponding classification: 1% - 5% sodium sulfite R20/22 1% - 5% ethylenediamine R10 R21/22 R34 R42/43 1% - 3% sulphuric acid R35 3. HAZARDS IDENTIFICATION If brought into contact with the eyes, the product causes irritation that may last for over 24 hours, and if brought into contact with the skin it causes significant inflammation with erythema, scabs, and oedema. If inhaled, the product may cause sensitisation of the airways, and if brought into contact with the skin it may cause sensitisation of the skin 14 All airborne proteins are (potentially) sensitising agents Many chemicals with powerful odours are not Solvents Thinners Perfumes Many (but not all) glues Some tips......and are thus improbable causes of sensitisation Be wary of diagnosing occupational asthma in anyone who is not working with a recognised respiratory sensitising agent 5

6 Recall 22 years work in a factory making foam insulating board New process January 2008 Q2: is he working with a recognised respiratory sensitising agent?... foam is a polymer made using polyol and MDI MDI = methylene phenyldiisocyanate 16 Hence Adult onset asthma Shortly after introduction of new process Works with known respiratory sensitising agent Symptoms improve on holiday Q3: what is the (prior) probability that this man has occupational asthma? Q4: how important is it to know (and how certain do you want to be)? 17 Occupational asthma or work-exacerbated asthma Occupational asthma (OA): That which has arisen de novo from an exposure encountered at work Work-exacerbated asthma (WEA): Pre-existing, recurrent or coincidental asthma that is exacerbated by exposure(s) in the workplace 18 6

7 Occupational asthma or work-exacerbated asthma: why does it matter? Continued exposure: Treatment: RPE: Cure? Legal? Relocation: Compensation: OA Worsens prognosis Useless Often useless (but ) 19 Occupational asthma or work-exacerbated asthma: why does it matter? OA WEA Continued exposure: Worsens prognosis Doesn t affect prognosis Treatment: Useless Effective RPE: Often useless Effective Cure? (but ) No Legal? No Relocation: Generally no Compensation: yes No 20 Getting it right matters Locating your patient: understanding the context (UK) In-house External provider Family doctor Occupational health (Surveillance) HSE Referral for opinion R I D D O R Case of OA Employer 21 Avoidance of further exposure relocation 7

8 Relocation of an employee with occupational asthma Avoidance of further exposure Retention in job, adjustment to tasks Re-training, protected position Re-location within firm Redundancy Size of workforce Attitude of employer/oh Experience of OA Self-employed So... Are you sure that you (both) want to go the whole way? On the one hand: You have a good chance of curing their asthma You will certainly stop it getting worse If you miss an occupational cause then treatment is useless On the other: They are likely to suffer major disruption at work and may become fairly unpopular there They may very well need to change (lose) their job and find it difficult to get another Hence: Getting it wrong can be disastrous Beware being on the safe side 24 Back to the case 1 Adult onset asthma Shortly after introduction of new process Works with known respiratory sensitising agent Symptoms improve on holiday Q5: is immunology going to be helpful? Negative specific IgE test for MDI Specific IgE in diisocyanate asthma is of: Low sensitivity (lots of false negatives) High specificity (few false positives) Hence helpful if positive 8

9 Using immunology intelligently in occupational asthma No, or not sure Is it a protein? IgE tests are: Highly sensitive Widely available Hence helpful when negative Ask for the right one(s) 25 Ask for expert help Back to the case 2 Adult onset asthma Shortly after introduction of new process Works with known respiratory sensitising agent Symptoms improve on holiday Specific immunology negative Q6: what might you do next? Comparison of function at and away from work Serial measurement of PEF: 26 Every two hours (six times daily) Four weeks At and away from work Plot of daily measurements: Mean Maximum Minimum Peak flow (max, mean, min) L/minute 27 9

10 28 Now where are you? Adult onset asthma Shortly after introduction of new process Works with known respiratory sensitising agent Symptoms improve on holiday Immunology unhelpful Serial PEFs look negative Q7: is this enough? How sure do you (both) need to be? Is there anything else on offer? Specific inhalation challenge Specific inhalation challenge 29 Controlled exposure to workplace agent Inpatient procedure Requires experience and expertise Available in few centres Used when: Other diagnostic approaches have not proved definitive A previously unrecognised agent is under consideration It s important to distinguish two or more agents Not for legal purposes Results of specific inhalation challenge 30 2 mins polyol 2.5 mins MDI 20 mins MDI 25 mins MDI 15 % change in baseline FEV Minutes Hours 10

11 Outcome Back at work Asymptomatic Off treatment Not everything is asthma Probably all infective Note that working with exposed to A brief summary Suspect an occupational cause in all cases of new, recurrent or deteriorating asthma in working adults Understand respiratory sensitising agent Have a feeling for your patient s location within the workplace Go in with all (4) eyes open Get it right: A positive diagnosis can be curative A false positive diagnosis can be disastrous Be specific about the agent(s) Act fast Caution is not always the better part of anything 33 11

Diagnosis, management and prevention of occupational asthma

Diagnosis, management and prevention of occupational asthma Setting higher standards Diagnosis, management and prevention of occupational asthma Concise guidance to good practice series April 2012 CONCISE GUIDANCE Clinical Medicine 2012, Vol 12, No 2: 156 9 Concise

More information

BOHRF BOHRF. Occupational Asthma. A Guide for Occupational Health Professionals, Safety Professionals and Safety Representatives BOHRF

BOHRF BOHRF. Occupational Asthma. A Guide for Occupational Health Professionals, Safety Professionals and Safety Representatives BOHRF Occupational Asthma A Guide for Occupational Health Professionals, Safety Professionals and Safety Representatives March 2010 British O Occupational Health Research Foundation This leaflet summarises the

More information

Occupational asthma. Dr Gordon Parker NHS. Consultant / Honorary Lecturer in Occupational Medicine. Lancashire Teaching Hospitals NHS Foundation Trust

Occupational asthma. Dr Gordon Parker NHS. Consultant / Honorary Lecturer in Occupational Medicine. Lancashire Teaching Hospitals NHS Foundation Trust Occupational asthma Dr Gordon Parker Consultant / Honorary Lecturer in Occupational Medicine Lancashire Teaching Hospitals NHS Foundation Trust NHS The good old bad old days Coal workers pneumoconiosis

More information

OCCUPATIONAL ASTHMA A GUIDE FOR GENERAL PRACTITIONERS AND PRACTICE NURSES

OCCUPATIONAL ASTHMA A GUIDE FOR GENERAL PRACTITIONERS AND PRACTICE NURSES OCCUPATIONAL ASTHMA A GUIDE FOR GENERAL PRACTITIONERS AND PRACTICE NURSES OCCUPATIONAL ASTHMA A guide for general practitioners and practice nurses. Occupational asthma accounts for up to 15% of all adult

More information

OCCUPATIONAL ASTHMA A GUIDE FOR OCCUPATIONAL PHYSICIANS AND OCCUPATIONAL HEALTH PRACTITIONERS

OCCUPATIONAL ASTHMA A GUIDE FOR OCCUPATIONAL PHYSICIANS AND OCCUPATIONAL HEALTH PRACTITIONERS OCCUPATIONAL ASTHMA A GUIDE FOR OCCUPATIONAL PHYSICIANS AND OCCUPATIONAL HEALTH PRACTITIONERS OCCUPATIONAL ASTHMA A guide for occupational physicians and occupational health practitioners Occupational

More information

2/28/2018. Occupation and Allergy The Basics and Not So Basics. Occupation and Allergy The Basics and Not So Basics. Outline

2/28/2018. Occupation and Allergy The Basics and Not So Basics. Occupation and Allergy The Basics and Not So Basics. Outline Occupation and Allergy The Basics and Not So Basics Jo Szram MD PhD Pulmonologist, Occupational and Environmental Medicine Director of Medical Education Royal Brompton and Harefield NHS Foundation Trust,

More information

Evaluations. Featured Speakers. Work Related Asthma: Recognition and Diagnosis. Disclosure Statements. Thank You to Our Sponsors: June 19, 2014

Evaluations. Featured Speakers. Work Related Asthma: Recognition and Diagnosis. Disclosure Statements. Thank You to Our Sponsors: June 19, 2014 Evaluations Nursing Contact Hours, CME and CHES credits are available. Please visit www.phlive.org to fill out your evaluation and complete the post-test. Featured Speakers Work Related Asthma: Recognition

More information

Work related asthma: a brief review. October 12, 2015 Mike Pysklywec MD MSc CCFP(EM) DOHS FCBOM

Work related asthma: a brief review. October 12, 2015 Mike Pysklywec MD MSc CCFP(EM) DOHS FCBOM Work related asthma: a brief review October 12, 2015 Mike Pysklywec MD MSc CCFP(EM) DOHS FCBOM Work-related asthma Occupational Asthma Work-aggravated Asthma Sensitizer-induced (allergic) Irritant-induced

More information

THE UNIVERSITY OF WESTERN ONTARIO Department of Epidemiology & Biostatistics. F. Lortie-Monette, MD, MSc, CSPQ, MBA OCCUPATIONAL ASTHMA

THE UNIVERSITY OF WESTERN ONTARIO Department of Epidemiology & Biostatistics. F. Lortie-Monette, MD, MSc, CSPQ, MBA OCCUPATIONAL ASTHMA THE UNIVERSITY OF WESTERN ONTARIO Department of Epidemiology & Biostatistics 2003 F. Lortie-Monette, MD, MSc, CSPQ, MBA OCCUPATIONAL ASTHMA 1 OCCUPATIONAL ASTHMA Occupational Asthma: the most prevalent

More information

Health Surveillance. Reference Documents

Health Surveillance. Reference Documents Health Surveillance Trevor Smith Consultant Occupational Physician Reference Documents Control of Substances Hazardous to Health Regulations 2002 HSE Guidance Note MS25 Medical Aspects of Occupational

More information

Asthma is a common condition, often starting or recurring

Asthma is a common condition, often starting or recurring PRACTICE Occupational asthma: an approach to diagnosis and management Susan M. Tarlo, Gary M. Liss Case A 40-year-old woman comes to the family practice clinic for a routine annual visit. She reports a

More information

STHMA IN THE WORKPLACE INFORMATION AND PREVENTION RF-531

STHMA IN THE WORKPLACE INFORMATION AND PREVENTION RF-531 STHMA IN THE WORKPLACE AA INFORMATION AND PREVENTION RF-531 GET THE FACTS AND WORK SMARTER Certain training and work environments carry health risks you should know about. Getting the facts will help you

More information

Work-related Asthma. Discussion paper prepared for. The Workplace Safety and Insurance Appeals Tribunal

Work-related Asthma. Discussion paper prepared for. The Workplace Safety and Insurance Appeals Tribunal Discussion paper prepared for The Workplace Safety and Insurance Appeals Tribunal November 1996 References updated January 2002 Revised March 2014 Prepared by: Dr. Susan M. Tarlo, MB BS FRCP(C) Respirologist

More information

New Hazards and Trends in Occupational Asthma

New Hazards and Trends in Occupational Asthma New Hazards and Trends in Occupational Asthma Trent Conference, Nottingham October 6 th 2016 Dr Jo Szram Consultant Respiratory Physician Occupational and Environmental Lung Disease Clinic j.szram@rbht.nhs.uk

More information

Occupational asthma PAUL CULLINAN AND ANTHONY NEWMAN TAYLOR INTRODUCTION

Occupational asthma PAUL CULLINAN AND ANTHONY NEWMAN TAYLOR INTRODUCTION 72 Occupational asthma PAUL CULLINAN AND ANTHONY NEWMAN TAYLOR Introduction 941 Causes of occupational asthma 942 Mechanisms of occupational asthma 943 Frequency of occupational asthma 944 Determinants

More information

Clinical Diagnosis of Occupational Asthma practice and challenges/opportunities ECETOC 2016

Clinical Diagnosis of Occupational Asthma practice and challenges/opportunities ECETOC 2016 Clinical Diagnosis of Occupational Asthma practice and challenges/opportunities ECETOC 2016 Paul Cullinan Royal Brompton Hospital and Imperial College London p.cullinan@imperial.ac.uk LUNGS AT WORK www.lungsatwork.org.uk

More information

Asthma in the workplace

Asthma in the workplace Work-related asthma Session 2105 Definitions, public health surveillance, and workplace medical monitoring Edward Lee Petsonk, M.D. Professor of Medicine i Section of Pulmonary and Critical Care Medicine

More information

Novel biomarkers of chemical-induced asthma: a murine model. Jeroen Vanoirbeek

Novel biomarkers of chemical-induced asthma: a murine model. Jeroen Vanoirbeek Novel biomarkers of chemical-induced asthma: a murine model Jeroen Vanoirbeek Asthma 1. Chronic airway disease: prevalence: 5-10%, 300.000 people affected world-wide 2. Reversible airflow limitation, airway

More information

ISOPA PRODUCT STEWARDSHIP PROGRAMMES. Walk the Talk MDI USERS

ISOPA PRODUCT STEWARDSHIP PROGRAMMES. Walk the Talk MDI USERS ISOPA PRODUCT STEWARDSHIP PROGRAMMES Walk the Talk MDI USERS 1 2 Walk the Talk - MDI Users Content Essential data Good practice When things go wrong... Dialogue 3 MDI Classification Harmful by inhalation

More information

American Osteopathic College of Occupational and Preventive Medicine 2011 Annual Meeting, Orlando, Florida, November 1, 2011

American Osteopathic College of Occupational and Preventive Medicine 2011 Annual Meeting, Orlando, Florida, November 1, 2011 Occupational Lung Disease Practical Applications of The Respiratory Standard Lance Walker D.O. MPH Objectives 1. Review of Occupational Lung Diseases 2. OSHA Respiratory Standard Refresher 3. Discuss spirometry

More information

Occupational Asthma in New Zealand Jeroen Douwes

Occupational Asthma in New Zealand Jeroen Douwes Occupational Asthma in New Zealand Jeroen Douwes Overview Definition and monitoring of occupational asthma Occupational asthma in New Zealand Respiratory health in New Zealand sawmill workers Definition

More information

O ccupational asthma (OA) is the most commonly

O ccupational asthma (OA) is the most commonly 58 ORIGINAL ARTICLE Changes in rates and severity of compensation claims for asthma due to diisocyanates: a possible effect of medical surveillance measures S M Tarlo, G M Liss, K S Yeung... See end of

More information

Isocyanate asthma: respiratory symptoms due to 1,5-naphthylene di-isocyanate

Isocyanate asthma: respiratory symptoms due to 1,5-naphthylene di-isocyanate Thorax, 1979, 34, 762-766 Isocyanate asthma: respiratory symptoms due to 1,5-naphthylene di-isocyanate M G HARRIES, P SHERWOOD BURGE, M SAMSON, A J NEWMAN TAYLOR, AND J PEPYS From the Brompton Hospital,

More information

SOLDER FUME and you 1

SOLDER FUME and you 1 SOLDER FUME and you 1 INTRODUCTION This leaflet tells you about possible health hazards from solder fume when using flux materials containing rosin, sometimes known as colophony. It also explains what

More information

ISOPA PRODUCT STEWARDSHIP PROGRAMMES. Walk the Talk MDI USERS

ISOPA PRODUCT STEWARDSHIP PROGRAMMES. Walk the Talk MDI USERS ISOPA PRODUCT STEWARDSHIP PROGRAMMES Walk the Talk MDI USERS Revision 2017 1 ISOPA Member Companies Walk the Talk - MDI Users Content Essential data Good practice When things go wrong... Dialogue 3 MDI

More information

ISOPA PRODUCT STEWARDSHIP PROGRAMMES. Walk the Talk MDI USERS. 1 Version09/06

ISOPA PRODUCT STEWARDSHIP PROGRAMMES. Walk the Talk MDI USERS. 1 Version09/06 ISOPA PRODUCT STEWARDSHIP PROGRAMMES Walk the Talk MDI USERS 1 Version09/06 2 Walk the Talk - MDI Users Content Essential data Good practice When things go wrong... Dialogue 3 MDI Classification according

More information

The Compensation of Allergic Disease ALLSA Conference, September 2017

The Compensation of Allergic Disease ALLSA Conference, September 2017 The Compensation of Allergic Disease ALLSA Conference, September 2017 Dr Shahieda Adams MBChB MMed (Occ Med) PhD OCCUPATIONAL MEDICINE DIVISION School of Public Health and Family Medicine University of

More information

BOHRF BOHRF BOHRF BOHRF

BOHRF BOHRF BOHRF BOHRF Occupational Contact Dermatitis and Urticaria A Guide for General Practitioners and Practice Nurses March 2010 British Occupational Health Research Foundat ion This leaflet summarises the key evidence

More information

Revised Protocol: Criteria for Designating Substances as. Occupational Asthmagens on the AOEC List of. Exposure Codes

Revised Protocol: Criteria for Designating Substances as. Occupational Asthmagens on the AOEC List of. Exposure Codes Revised Protocol: Criteria for Designating Substances as Occupational Asthmagens on the AOEC List of Exposure Codes Revised September 2008 1 I. Introduction This is a project to evaluate the current AOEC

More information

Safety First Plus. Safety, Health and Environment (SHE) Prevention of Work Related Skin Disease. Maritime Submarines SAFETY FIRST PLUS

Safety First Plus. Safety, Health and Environment (SHE) Prevention of Work Related Skin Disease. Maritime Submarines SAFETY FIRST PLUS Safety First Plus Safety, Health and Environment (SHE) Prevention of Work Related Skin Disease Maritime Submarines THINK SAFE. ACT SAFE. BE SAFE Prevention of Work Related Skin Disease 2013 WHAT IS SKIN

More information

Enzyme Safety Management: Thanks for joining us today!

Enzyme Safety Management: Thanks for joining us today! Enzyme Safety Management: Thanks for joining us today!.the webinar will begin shortly. The webinar will be recorded. Please make sure to be on mute so that we can ensure a good quality of the audio. 1

More information

Health and Safety in Nail Salons

Health and Safety in Nail Salons Health and Safety in Nail Salons Page 1 of 12 Health and Safety Advice Note: Nail Salons Acrylic Nails The problem A number of the products used in the artificial nail business contain substances which

More information

The Health and Occupation Research Network THOR ( UK & Republic of Ireland )

The Health and Occupation Research Network THOR ( UK & Republic of Ireland ) The Health and Occupation Research Network THOR ( UK & Republic of Ireland ) Prof Raymond Agius Centre for Occupational & Environmental Health The University of Manchester Methodologies to identify work-related

More information

Name Of Substance & [EINECS No] Concentration Symbol R Phrases n-butyl acetate[ ] 1-10 % R Hexamethylene diisocyanate[ ]

Name Of Substance & [EINECS No] Concentration Symbol R Phrases n-butyl acetate[ ] 1-10 % R Hexamethylene diisocyanate[ ] 1 IDENTIFICATION OF THE PREPARATION AND COMPANY 1. Product Name: Corroless RF 65 Hardener Product Code: 4054991 Revision: 6.00 Issue Date: 08/01/15 2. Intended Use: Industrial Hardener (polyurethane finishes)

More information

Changing Patterns of Occupational Respiratory Disease. Malcolm Sim

Changing Patterns of Occupational Respiratory Disease. Malcolm Sim Changing Patterns of Occupational Respiratory Disease Malcolm Sim Centre for Occupational and Environmental Health School of Public Health and Preventive Medicine Monash University Table 2. Estimates

More information

SOLDER Revision Date: 30/05/2003

SOLDER Revision Date: 30/05/2003 Page 1 of 5 MSDS No.: 0135 1. IDENTIFICATION OF THE SUBSTANCE / PREPARATION AND THE COMPANY / UNDERTAKING 1.1. PRODUCTS IDENTIFICATION: Solder 1.2. USE OF SUBSTANCE: No information supplied 1.3. COMPANY:

More information

Prepared by Sarah Bozeman, MD, University of Mississippi Healthcare, and John Seyerle, Ohio State University

Prepared by Sarah Bozeman, MD, University of Mississippi Healthcare, and John Seyerle, Ohio State University Allergy and Immunology Review Corner: Chapter 53 of Middleton s Allergy Principles and Practice, Seventh Edition, edited by N. Franklin Adkinson, et al. Chapter 53: Occupational Asthma Prepared by Sarah

More information

Health Consequences of Exposure to Green Polyurethane Spray Foam

Health Consequences of Exposure to Green Polyurethane Spray Foam Health Consequences of Exposure to Green Polyurethane Spray Foam CWG Mee'ng March 27, 2012 Carrie A. Redlich MD, MPH Yale Occupational & Environmental Medicine Program Exposure to Green Polyurethane Spray

More information

Your health and safety guide to Hazardous substances

Your health and safety guide to Hazardous substances Your health and safety guide to Hazardous substances EDITION NO. 2 FEBRUARY 2008 HAZARD GUIDE In this series Hazards Your health and safety guide to asbestos Your health and safety guide to confined spaces

More information

Occupational asthma in a steel coating plant

Occupational asthma in a steel coating plant British Journal of Industrial Medicine 1985;42:517-524 Occupational asthma in a steel coating plant KATHERINE M VENABLES,' M B DALLY,' P S BURGE,' C A C PICKERING,2 AND A J NEWMAN TAYLOR From the Department

More information

Allwin Mercer Dr Andrew Zurek

Allwin Mercer Dr Andrew Zurek Allwin Mercer Dr Andrew Zurek 1 in 11 people are currently receiving treatment for asthma (5.4 million people in the UK) Every 10 seconds, someone is having a potentially life-threatening asthma attack

More information

Effect of peak expiratory flow data quantity on diagnostic sensitivity and specificity in occupational asthma

Effect of peak expiratory flow data quantity on diagnostic sensitivity and specificity in occupational asthma Eur Respir J 2004; 23: 730 734 DOI: 10.1183/09031936.04.00027304 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2004 European Respiratory Journal ISSN 0903-1936 Effect of peak expiratory

More information

Practical Issues in Asthma Management OCCUPATIONAL ASTHMA. Dr. P. Sherwood Burge, Consultant Physician, Birmingham Heartlands Hospital, Birmingham, UK

Practical Issues in Asthma Management OCCUPATIONAL ASTHMA. Dr. P. Sherwood Burge, Consultant Physician, Birmingham Heartlands Hospital, Birmingham, UK Practical Issues in Asthma Management OCCUPATIONAL ASTHMA Dr. P. Sherwood Burge, Consultant Physician, Birmingham Heartlands Hospital, Birmingham, UK Issue number 24, 2000 Practical Issues in Asthma Management

More information

HEALTH AND SAFETY DATA SHEET

HEALTH AND SAFETY DATA SHEET HEALTH AND SAFETY DATA SHEET 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND COMPANY/UNDERTAKING PRODUCT NAME: BIOLOGICAL LAUNDRY DETERGENT PART NO: 0980 SUPPLIER: Envomatic Foxholes Road Leicester

More information

Occupational Asthma and Work- Exacerbated Asthma* Factors Associated With Time to Diagnostic Steps

Occupational Asthma and Work- Exacerbated Asthma* Factors Associated With Time to Diagnostic Steps Original Research ASTHMA Occupational Asthma and Work- Exacerbated Asthma* Factors Associated With Time to Diagnostic Steps Marlene S. Santos, MD; Hyejung Jung, MSc; Javad Peyrovi, MD; Wendy Lou, PhD;

More information

B R E ATHE FR EELY. Do you breathe freely? Controlling exposures to prevent occupational lung disease in the construction industry

B R E ATHE FR EELY. Do you breathe freely? Controlling exposures to prevent occupational lung disease in the construction industry B R E ATHE FR EELY Controlling exposures to prevent occupational lung disease in the construction industry Do you breathe freely? www.breathefreely.org.uk 99% health Approx 13,000 died from work related

More information

SAFETY DATA SHEET. Use of substance / mixture: FOR PROFESSIONAL USE ONLY 2 Parts of G-Fix Gold Resin to be used with 1 Part G-Fix Gold Hardener.

SAFETY DATA SHEET. Use of substance / mixture: FOR PROFESSIONAL USE ONLY 2 Parts of G-Fix Gold Resin to be used with 1 Part G-Fix Gold Hardener. SAFETY DATA SHEET Page: 1 Revision date: 05.01.12 Revision No: 4 Section 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product name: Index number: Product

More information

Latex allergy. Occupational aspects of management

Latex allergy. Occupational aspects of management Latex allergy Occupational aspects of management for Evidence-based guidance employees This leaflet is about what to do if you are allergic to latex used at work, and measures that can be taken to minimise

More information

Bronchial provocation testing. ICOH Mexico David Lee Sherson, Odense. (Paul Cullinan, London)

Bronchial provocation testing. ICOH Mexico David Lee Sherson, Odense. (Paul Cullinan, London) Bronchial provocation testing ICOH Mexico 2012 David Lee Sherson, Odense (Paul Cullinan, London) Outline definitions, concepts and some history indications methods difficulties summary: should every department

More information

PRODUCT SAFETY DATA SHEET

PRODUCT SAFETY DATA SHEET PRODUCT SAFETY DATA SHEET 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING 1.1. Product Identifiers Product Name: Powder paints 1.2. Relevant Identified uses of the substance

More information

Exposure to Mineral and Chemical Hazards

Exposure to Mineral and Chemical Hazards Exposure to Mineral and Chemical Hazards The following mineral and chemical hazards are discussed here: asbestos, lead, dust, detergents and cleaning products, and pesticides. Asbestos Asbestos is a fibrous

More information

and Air Sampling - Construction Industry

and Air Sampling - Construction Industry Workplace Airborne Hazards and Air Sampling - Construction Industry and Air Sampling - Construction Industry Midland Construction Safety Association 8 th August 2017 Jeremy Evans - Sales Development Manager

More information

Work-related asthma, Dr Ryan Hoy Alfred Hospital, Melbourne Monash Centre for Occupational and Environmental Health

Work-related asthma, Dr Ryan Hoy Alfred Hospital, Melbourne Monash Centre for Occupational and Environmental Health Work-related asthma, 2016 Alfred Hospital, Melbourne Monash Centre for Occupational and Environmental Health Overview Asthma in the workplace Is it asthma? Work-exacerbated asthma Occupational asthma Diagnosis

More information

Safety Data Sheet PT25R

Safety Data Sheet PT25R Safety Data Sheet dated 14/7/2011, version 3 1. IDENTIFICATION OF THE PRODUCT AND OF THE COMPANY Trade name: Product type and use: Company: LEGOR GROUP S.p.A. Via del Lavoro, 1 36050 Bressanvido (VI) Italy

More information

Version 1.1 SDB_GB Revision Date Print Date Identification of the substance/mixture and of the company/undertaking

Version 1.1 SDB_GB Revision Date Print Date Identification of the substance/mixture and of the company/undertaking 1. Identification of the substance/mixture and of the company/undertaking 1.1 Product identifier Trade name : 1.2 Relevant identified uses of the substance or mixture and uses advised against Use of the

More information

Control of Substances Hazardous to Health (COSHH) Regulations 2002

Control of Substances Hazardous to Health (COSHH) Regulations 2002 Control of Substances Hazardous to Health (COSHH) Regulations 2002 1. Purpose This document provides guidance to staff on how to comply with the COSHH Regulations 2002 (as amended) and in particular informs

More information

: Corian Joint Adhesive Kit - Component A

: Corian Joint Adhesive Kit - Component A This SDS adheres to the standards and regulatory requirements of Great Britain and may not meet the regulatory requirements in other countries. 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE

More information

Guidelines for Addressing Allergies and Sensitivities in the Workplace Next review: April 2019 I. PURPOSE II. INTRODUCTION III.

Guidelines for Addressing Allergies and Sensitivities in the Workplace Next review: April 2019 I. PURPOSE II. INTRODUCTION III. I. PURPOSE The Government of Saskatchewan is committed to ensuring workplace health, safety and wellness. Allergens and sensitivities present a health concern for some individuals in the workplace and

More information

ASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss?

ASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss? ASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss? Randall W. Brown, MD MPH AE-C Association of Asthma Educators Annual Conference July 20, 2018 Phoenix, Arizona FACULTY/DISCLOSURES Randall Brown,

More information

ASTHMA PROTOCOL CELLO

ASTHMA PROTOCOL CELLO ASTHMA PROTOCOL CELLO Leiden May 2011 1 Introduction This protocol includes an explanation of the clinical picture, diagnosis, objectives, non medical and medical therapy and a scheme for inhaler dosage.

More information

Diagnosis, Treatment and Management of Asthma

Diagnosis, Treatment and Management of Asthma Diagnosis, Treatment and Management of Asthma Asthma is a complex disorder characterized by variable and recurring symptoms, airflow obstruction, bronchial hyperresponsiveness, and an underlying inflammation.

More information

information Chronic Obstructive Pulmonary Disease - COPD (1 of 5) What is COPD? What is going on in my lungs? What are the symptoms of COPD?

information Chronic Obstructive Pulmonary Disease - COPD (1 of 5) What is COPD? What is going on in my lungs? What are the symptoms of COPD? information If you need this information in another language or medium (audio, large print, etc) please contact the Patient Advice and Liaison Service (PALS) on 0800 374 208 email: pal.service@ salisbury.nhs.uk.

More information

Guidelines for the management of work-related asthma

Guidelines for the management of work-related asthma Eur Respir J 2012; 39: 529 545 DOI: 10.1183/09031936.00096111 ERS TASK FORCE REPORT Guidelines for the management of work-related asthma X. Baur, T. Sigsgaard, T.B. Aasen, P.S. Burge, D. Heederik, P. Henneberger,

More information

Chronic Cough. Dr Peter George Consultant Respiratory Physician Royal Brompton and Harefield Hospitals

Chronic Cough. Dr Peter George Consultant Respiratory Physician Royal Brompton and Harefield Hospitals Chronic Cough Dr Peter George Consultant Respiratory Physician Royal Brompton and Harefield Hospitals Overview Common causes of chronic cough Important diagnoses not to miss How to investigate a cough

More information

Safety Data Sheet EPOJET LV parte A

Safety Data Sheet EPOJET LV parte A Safety Data Sheet dated 10/9/2009, version 5 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING Trade name: Product type and use: Epoxy resins. Supplier: MAPEI S.p.A. -Via Cafiero

More information

Get Healthy Stay Healthy

Get Healthy Stay Healthy Asthma Management WHAT IS ASTHMA? Asthma causes swelling and inflammation in the breathing passages that lead to your lungs. When asthma flares up, the airways tighten and become narrower. This keeps the

More information

Dermatitis. Occupational aspects of management

Dermatitis. Occupational aspects of management Dermatitis Occupational aspects of management Evidence-based guidance for healthcare professionals Introduction This leaflet summarises the findings from a review of the published scientific literature

More information

Marks & Spencer Homecare Products Ingredients and Safety Data Sheet

Marks & Spencer Homecare Products Ingredients and Safety Data Sheet Marks & Spencer Homecare Products Ingredients and Safety Data Sheet Sensitive Super concentrated non-biological laundry liquid UPC: 0474795 Series Number: 4766 Marks & Spencer PLC Waterside House 35 North

More information

Pathology of Asthma Epidemiology

Pathology of Asthma Epidemiology Asthma A Presentation on Asthma Management and Prevention What Is Asthma? A chronic disease of the airways that may cause Wheezing Breathlessness Chest tightness Nighttime or early morning coughing Pathology

More information

SAFETY DATA SHEET SAWCUT 1000 Page: 1 Compilation date: 12/04/2016 Revision No: 1

SAFETY DATA SHEET SAWCUT 1000 Page: 1 Compilation date: 12/04/2016 Revision No: 1 Page: 1 Compilation date: 12/04/2016 Revision No: 1 Section 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product name: 1.2. Relevant identified uses

More information

SAFETY DATA SHEET according to Regulation (EU) 2015/830

SAFETY DATA SHEET according to Regulation (EU) 2015/830 CP1479 v1.4 RS 756-8875, 756-8884, 756-8893, 756-8897, 756-8913, 8-7642, 8-7649, 8-7655 RS CLP/GHS revision date : 1/3/18 SAFETY DATA SHEET according to Regulation (EU) 215/83 Page 1/5 SECTION 1: Identification

More information

Asthma: diagnosis and monitoring

Asthma: diagnosis and monitoring Asthma: diagnosis and monitoring NICE guideline: short version Draft for second consultation, July 01 This guideline covers assessing, diagnosing and monitoring suspected or confirmed asthma in adults,

More information

This SDS adheres to the standards and regulatory requirements of Great Britain and may not meet the regulatory requirements in other countries.

This SDS adheres to the standards and regulatory requirements of Great Britain and may not meet the regulatory requirements in other countries. This SDS adheres to the standards and regulatory requirements of Great Britain and may not meet the regulatory requirements in other countries. 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING

More information

Coating powders are mixtures of pigments, resins, curing. As the coating powder is sprayed through the nozzle of the

Coating powders are mixtures of pigments, resins, curing. As the coating powder is sprayed through the nozzle of the CONTROLLING EXPOSURE TO COATING POWDERS INTRODUCTION What are coating powders? Coating powders are mixtures of pigments, resins, curing agents and other additives. They give a durable finish and are used

More information

Before you start go to page 2. Leeds West Clinical Commissioning Group

Before you start go to page 2. Leeds West Clinical Commissioning Group Leeds West Clinical Commissioning Group If you or one of your friends has asthma we want you to tell us how you feel. We also want your parents or carers to tell us how they help you look after yourself.

More information

1. Identification of the substance/mixture and of the company/undertaking

1. Identification of the substance/mixture and of the company/undertaking MATERIAL SAFETY DATA SHEET BICASEAL PUTTY ACTIVATOR ISSUE Number: 1 ISSUE DATE: 29 th April 2015 1. Identification of the substance/mixture and of the company/undertaking 1.1 Product identifier Bicaseal

More information

material safety data sheet

material safety data sheet Dermatophagoidus pteronyssinus freeze dried extract Page: 1/6 1. Identification of the substance & the company Chemical name : Dermatophagoidus pteronyssinus freeze dried extract Chemical formula biological

More information

MATERIAL SAFETY DATA SHEET. Product Pirtek Hydraulic HVI Range Page 1 of 5 Date Oct Revision 02

MATERIAL SAFETY DATA SHEET. Product Pirtek Hydraulic HVI Range Page 1 of 5 Date Oct Revision 02 Product Pirtek Hydraulic HVI Range Page 1 of 5 1 Identification of the Substance/Preparation and Company Supplier: Address: Pirtek (UK) Limited 199 Acton Park Estate, The Vale Acton, London W3 7QS Contact

More information

HEALTH & SAFETY DATA SHEET

HEALTH & SAFETY DATA SHEET HEALTH & SAFETY DATA SHEET CADCO DOMING RESIN: PART B TYPE 2 As used in Cadco PC-1 Low Profile; C-1C High Dome; C-80; C-80XM; P-20; P-20XM; P-21; P-60; P-60XM; P-60C 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION

More information

WORK-RELATED ASTHMA: Michael Pysklywec Sonia Lal

WORK-RELATED ASTHMA: Michael Pysklywec Sonia Lal WORK-RELATED ASTHMA: Michael Pysklywec, MD MSc CCFP(EM) DOHS FCBOM Occupational Health Clinics for Ontario Workers McMaster University, Department of Clinical Epidemiology & Biostatistics Sonia Lal CRSP,

More information

SAFETY DATA SHEET. Section 1: Identification of the substance/mixture and of the company/undertaking. Section 2: Hazards identification

SAFETY DATA SHEET. Section 1: Identification of the substance/mixture and of the company/undertaking. Section 2: Hazards identification Page: 1 Compilation date: 01/08/2010 Revision date: 03/10/2013 Revision No: 7 Section 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product name: Product

More information

Asthma-like syndrome in school children after accidental exposure to xylene and methylene diphenyl diisocyanate

Asthma-like syndrome in school children after accidental exposure to xylene and methylene diphenyl diisocyanate J Microbiol Immunol Infect. 2008;41:337-341 Asthma-like syndrome in school children after accidental exposure to xylene and methylene diphenyl diisocyanate Ren-Long Jan 1,2, Shin-Hong Chen 1,3, Ho-Yuan

More information

SAFETY DATA SHEET. Section 1: Identification of the substance/mixture and of the company/undertaking. Section 2: Hazards identification

SAFETY DATA SHEET. Section 1: Identification of the substance/mixture and of the company/undertaking. Section 2: Hazards identification Page: 1 Compilation date: 15/05/15 Revision No: 1 Section 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product name: CAS number: 9016-87-9 1.2. Relevant

More information

Material Safety Data Sheet acc. to ISO/DIS 11014

Material Safety Data Sheet acc. to ISO/DIS 11014 Page 1/5 1 Identification of the substance/mixture and of the company/undertaking Product Identifier Catalog Number: 211102 Details of the supplier of the safety data sheet Manufacturer/Supplier: BD Diagnostic

More information

Material Safety Data Sheet

Material Safety Data Sheet Material Safety Data Sheet Date Reviewed and Issued: February 16, 2013 Section 1. Identification: Proven Winners Controlled Release Fertilizer Product Names: Sunshine Proven Winners Premium Continuous

More information

Safety Data Sheet MAPEPROOF ESM parte A

Safety Data Sheet MAPEPROOF ESM parte A Safety Data Sheet dated 23/4/2010, version 6 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING Trade name: Product type and use: Epoxy resins. Supplier: MAPEI S.p.A. -Via Cafiero

More information

OCCUPATIONAL DERMATITIS

OCCUPATIONAL DERMATITIS OCCUPATIONAL DERMATITIS Written By: Occupational Disease Working Group A Sub-Committee of Occupational Health and Safety Council of Ontario Dermatitis in the Workplace What You Should Know Occupational

More information

SUMMARY DECISION NO. 718/98. Asthma.

SUMMARY DECISION NO. 718/98. Asthma. SUMMARY DECISION NO. 718/98 Asthma. The worker started working as a bricklayer in 1974 and as an industrial bricklayer in 1980. He began experiencing respiratory symptoms in 1982. He continued working

More information

Diagnosis and Management of Asthma in Children based on the British Thoracic Society and Scottish Intercollegiate Guidelines Network September 2016

Diagnosis and Management of Asthma in Children based on the British Thoracic Society and Scottish Intercollegiate Guidelines Network September 2016 Diagnosis and Management of Asthma in Children based on the British Thoracic Society and Scottish Intercollegiate Guidelines Network September 2016 Diagnosis: There is no lower limit to the age at which

More information

Inhalation challenges with agents causing occupational asthma

Inhalation challenges with agents causing occupational asthma Eur Respir J 1997; 10: 2612 2629 DOI: 10.1183/09031936.97.10112612 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1997 European Respiratory Journal ISSN 0903-1936 REVIEW Inhalation challenges

More information

1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING RIO BUCATO BIMBO. Liquid laundry detergent for machine and hand usage

1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING RIO BUCATO BIMBO. Liquid laundry detergent for machine and hand usage 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING Product name: Use: Company: Address: Liquid laundry detergent for machine and hand usage Drop Chemicals Ltd. Triq il-birrerija

More information

Asthma Description. Asthma is a disease that affects the lungs defined as a chronic inflammatory disorder of the airways.

Asthma Description. Asthma is a disease that affects the lungs defined as a chronic inflammatory disorder of the airways. Asthma Asthma Description Asthma is a disease that affects the lungs defined as a chronic inflammatory disorder of the airways. Symptoms of asthma In susceptible individuals, this inflammation causes recurrent

More information

Safety Data Sheet ULTRAPLAN RENOVATION

Safety Data Sheet ULTRAPLAN RENOVATION Safety Data Sheet dated 13/5/2010, version 1 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING Trade name: Product type and use: Cement based levelling mortar. Supplier: MAPEI

More information

Occupational asthma in an electronics factory

Occupational asthma in an electronics factory Occupational asthma in an electronics factory P SHERWOOD BURGE, W PERKS, I From the Brompton Hospital, London SW3 6HP, UK Thorax, 1979, 34, 13-18 M O'BRIEN, R HAWKINS, AND M GREEN ABSTRAcT Workers in a

More information

Stowe School Asthma Policy

Stowe School Asthma Policy 1) POLICY STATEMENT Stowe School is an inclusive community that aims to support pupils with asthma, ensuring they participate fully in all aspects of school life. It recognises that asthma is a widespread,

More information

Material Safety Data Sheet acc. to ISO/DIS 11014

Material Safety Data Sheet acc. to ISO/DIS 11014 Page 1/5 1 Identification of the substance/mixture and of the company/undertaking Product Identifier Catalog Number: 211059 Details of the supplier of the safety data sheet Manufacturer/Supplier: BD Diagnostic

More information

Who Is at Risk for Asthma? Who develope asthma?

Who Is at Risk for Asthma? Who develope asthma? Keya Ghosh What is Asthma? Disease that inflames and narrows the airways. Asthma causes recurring periods of wheezing (a whistling sound when you breathe), chest tightness, shortness of breath, and coughing.

More information

Outpatient Guideline for the Diagnosis and Management of Asthma

Outpatient Guideline for the Diagnosis and Management of Asthma Outpatient Guideline for the Diagnosis and Management of Asthma Initial Visit Follow-Up Visits See page 2 Asthma Diagnosis See page 3 Classifying Asthma Severity and Initiating Treatment See pages 2 and

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET This safety data sheet conforms to Regulation (EC) No. 1272/2008. Version 3 18.09.15 1.0 IDENTIFICATION OF THE SUBSTANCE/ PREPARATION AND COMPANY 1.1 PRODUCT IDENTIFIERS Product name : AVD Foam (Aqueous

More information